Glossary

    All MedTech Terms

    513 sourced definitions covering the regulatory, quality, software, and cybersecurity vocabulary of modern medical devices.

    Showing 1–24 of 47

    Investment & Finance

    409A Valuation

    An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options.

    Investment & Finance

    Anti-Dilution Protection

    Adjustment that protects investors if the company raises a future round at a lower price.

    Investment & Finance

    Board of Directors

    The governing body elected by stockholders that oversees management, approves major corporate actions, and typically includes investor-designated seats after venture financing.

    Investment & Finance

    Bridge Round

    Interim financing between priced rounds, usually convertible.

    Investment & Finance

    Burn Rate

    Rate at which a company spends cash, typically expressed monthly.

    Investment & Finance

    Burn Rate and Runway

    Monthly net cash consumption (burn) and months of cash remaining (runway).

    Investment & Finance

    Capitalization Table(Cap Table)

    Ledger of all securities issued by a company and who owns them.

    Investment & Finance

    Common Stock

    The base class of equity typically held by founders and employees, standing last in the distribution waterfall behind creditors and preferred stockholders.

    Investment & Finance

    Convertible Note

    Short-term debt that converts into equity at a future financing round.

    Investment & Finance

    Dilution

    Reduction in existing shareholder ownership when new shares are issued.

    Investment & Finance

    Distribution Waterfall

    The order in which sale or liquidation proceeds are paid out to creditors, preferred stockholders, and common stockholders based on liquidation preferences and conversion decisions.

    Investment & Finance

    Down Round

    Financing at a lower per-share price than the previous round.

    Investment & Finance

    Drag-Along and Tag-Along Rights

    aka Drag-along · Tag-along · Co-sale rights

    Stockholder agreement provisions that compel minority holders to join a sale (drag) or entitle them to participate pro rata in a major holder's sale (tag).

    Investment & Finance

    Due Diligence

    Investigation of a company before an investment, financing, or acquisition.

    Investment & Finance

    Earn-Out

    aka Contingent value right · CVR · Milestone consideration

    Acquisition consideration paid contingently after closing based on achievement of agreed milestones (regulatory, revenue, or technical).

    Investment & Finance

    Employee Option Pool

    Shares reserved for issuance to employees as stock options.

    Investment & Finance

    Exit Multiple

    Valuation ratio applied at exit, e.g., enterprise value to revenue.

    Investment & Finance

    Fully Diluted Shares

    The total share count assuming exercise or conversion of all outstanding options, warrants, convertible securities, and reserved but unissued option pool shares.

    Investment & Finance

    Initial Public Offering(IPO)

    First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.

    Investment & Finance

    Limited Partner / General Partner(LP / GP)

    The two principal roles in a venture capital fund: LPs provide capital, GPs manage the fund and make investment decisions.

    Investment & Finance

    Liquidation Preference

    Right of preferred shareholders to be paid before common in an exit.

    Investment & Finance

    Liquidity Event

    Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.

    Investment & Finance

    Lock-Up Period

    A contractually specified period after an IPO or acquisition during which insiders and pre-existing stockholders are restricted from selling their shares.

    Investment & Finance

    Mergers and Acquisitions(M&A)

    Transactions in which one company acquires or combines with another, the dominant MedTech exit path, typically a strategic acquisition by an established player.